Company Filing History:
1 out of 1,274 
1 out of 504 
1 out of 52 Years Active: 2021
Title: Deepika Polineni: Innovator in Lung Disease Treatment
Introduction
Deepika Polineni is a notable inventor based in Kansas City, MI (US). She has made significant contributions to the field of medicine, particularly in the treatment of lung diseases. Her innovative work focuses on the use of MTAP inhibitors, which have the potential to transform therapeutic approaches for conditions such as cystic fibrosis and chronic obstructive pulmonary disease.
Latest Patents
Deepika Polineni holds a patent for the invention titled "Use of MTAP inhibitors for the treatment of lung disease." This invention relates to the application of 5'-methylthioadenosine phosphorylase (MTAP) inhibitors in treating lung diseases associated with inflammation. The small molecule inhibitors of MTAP can help sustain the accumulation of endogenous MTA to therapeutically beneficial levels, resulting in decreased inflammation in patients suffering from cystic fibrosis and COPD.
Career Highlights
Throughout her career, Deepika has worked with prestigious institutions, including the University of North Carolina at Chapel Hill and Albert Einstein College of Medicine. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Deepika has collaborated with notable colleagues such as Charles R. Esther, Jr. and Michael R. Knowles. These partnerships have further enhanced her research and innovation in the medical field.
Conclusion
Deepika Polineni's work in developing MTAP inhibitors represents a significant advancement in the treatment of lung diseases. Her dedication to innovation and collaboration continues to inspire progress in medical research and patient care.